The Inflation Reduction Act is a Foot in the Door for Containing Health Care Costs August 25, 2022 Perspective In this column for the JAMA Forum, KFF’s Larry Levitt explores the Medicare drug-price negotiation provisions and other significant drug-price changes in the Inflation Reduction Act and their potential to lead to further efforts to address health care costs.
August 24 Web Event: Health Care Inflation in the U.S. August 24, 2022 Event As the 2022 mid-term elections approach, inflation and gas prices are on the top of voters’ minds. While health care prices have often risen faster than the rest of the economy, the prices for medical services are generally set in advance – often tied to the calendar year – creating…
Key Facts About Medicare Part D Enrollment and Costs in 2022 August 17, 2022 Issue Brief This analysis provides the latest data about Medicare Part D enrollment, premiums, and cost sharing in 2022 and trends over time, including information about stand-alone prescription drug plans (PDPs) and Medicare Advantage prescription drug plans.
The Biggest Health Care Reform in a Decade Could Lower Your Costs August 13, 2022 Perspective Larry Levitt writes about the political and practical impact of the health care provisions in the Inflation Reduction Act in The New York Times guest essay, “The Biggest Health Care Reform in a Decade Could Lower Your Costs.”
Medicare Part D Enrollees Without Low-Income Subsidies (LIS) With Drug Spending Above the Catastrophic Threshold August 3, 2022 State Indicator
Weighted Average Monthly Premium for Medicare Part D Stand-alone Prescription Drug Plans August 3, 2022 State Indicator
Insulin Out-of-Pocket Costs in Medicare Part D July 28, 2022 Issue Brief Addressing the cost of insulin continues to be at the forefront of policy discussions around prescription drugs. This analysis describes out-of-pocket spending on insulin products by Medicare beneficiaries enrolled in Part D drug plans, along with state-level use and spending data.
How Would the Prescription Drug Provisions in the Senate Reconciliation Proposal Affect Medicare Beneficiaries? July 27, 2022 Issue Brief The brief provides a quick explainer of the prescription drug provisions in legislative text released by the Senate Finance Committee to be included in a forthcoming reconciliation bill and presents new estimates on how many Medicare beneficiaries could be helped by those provisions.
May 23 Web Event: Executive Actions to Address Prescription Drug Affordability in the U.S. May 23, 2022 Event U.S. prescription drug spending per person is about double what it is in peer countries and about 8 in 10 U.S. adults say the cost of prescription drugs is unreasonable. With the public ranking lowering out-of-pocket costs for prescription drugs the top health care priority for Congress, lawmakers have been…
